Share-based Payment Arrangements (Tables)

6 Months Ended

Jun. 25, 2022

Amounts Recognized in Financial Statements with Respect to Plans

Amounts recognized in the financial statements with respect to these Plans are as follows (in thousands):

	Twenty Six Weeks Ended						Thirteen Weeks Ended
	June 25, 2022			June 26, 2021			June 25, 2022			June 26, 2021
Total cost of the Plans during the period	$	5,810		$	10,893		$	3,815		$	6,864
Amount of related income tax benefit recognized during the period		(4,270	)		(3,717	)		(910	)		(2,376	)
Net cost of the Plans during the period	$	1,540		$	7,176		$	2,905		$	4,488

Schedule of Information on Restricted Stock Units

The following table summarizes information regarding the Company’s outstanding restricted stock unit (“RSU”) awards with either a performance condition or a market condition under the Plans:

	Number of RSUs			Weighted Average Grant Date Fair Value
Outstanding at December 25, 2021		209,399		$	102.90
Granted		49,596		$	139.67
Shares earned in excess of target (1)		91,497		$	92.58
Vested shares, including shares earned in excess of target		(174,366	)	$	96.14
Forfeited		(16,768	)	$	105.35
Outstanding at June 25, 2022		159,358		$	115.55

(1) Represents additional shares earned under each of the February 2, 2017; February 2, 2018 and February 1, 2019 RSU awards as fiscal year 2021 financial results exceeded target performance level.

Schedule of Information on Non-Vested Restricted Stock and Deferred Stock Units

The following table summarizes information regarding the Company’s outstanding shares of non-vested restricted stock and Deferred Stock Units (defined below) under the Plans:

	Number of Shares and Deferred Stock Units			Weighted Average Grant Date Fair Value
Non-vested at December 25, 2021		56,436		$	125.16
Granted		23,791		$	153.11
Vested		(27,074	)	$	122.68
Forfeited		(2,302	)	$	108.59
Non-vested at June 25, 2022		50,851		$	140.31

Summary of Information Regarding Stock Options

The following table summarizes information regarding the Company’s outstanding stock options under the Plans:

	Number of Options			Weighted Average Exercise Price per Share		Weighted Average Remaining Contractual Term (years)		Aggregate Intrinsic Value (000s)
Options outstanding at December 25, 2021		8,570		$	55.42
Exercised		(3,500	)	$	54.01
Options outstanding at June 25, 2022		5,070		$	56.40		0.6	$	464
Options exercisable at June 25, 2022		5,070		$	56.40		0.6	$	464